JOIN US to Learn about two new initiatives: YC for Biotech and Health Tech @ JLABS

Add this event to your calendar:
27/07/2018 19:00 27/07/2018 21:00 America/Los_Angeles JOIN US to Learn about two new initiatives: YC for Biotech and Health Tech @ JLABS Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY
July
27
Event

JOIN US to Learn about two new initiatives: YC for Biotech and Health Tech @ JLABS

Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA

July 27, 2018 from 19:00 PM to 21:00 PM (PST)

$10 - $35


Program Overview:

Supporting start-ups is an important mission for many reasons, including making people’s lives better and getting solutions to patients faster. Although incubator or accelerator programs vary in style, length, facility and functions, we share the common goal of moving companies forward.

After years of successfully supporting new companies both Y-Combinator and Johnson & Johnson Innovation, JLABS are expanding the areas they cover. Y-Combinator has introduced a new life science program and JLABS has a new health tech initiative. 

Please join us to learn more about becoming part of these programs and how they can benefit your start-up. 


           

 

Speakers 
Diego Rey | Visiting Partner, Y Combinator read bio» 
Kate Merton | Head, JLABS @ NYC & Boston, Johnson & Johnson Innovation read bio» 
Walker McHugh | Co-founder   PreDxion Bio read bio» 


Agenda:
 
5:00 PM | Registration and Networking 
5:15 PM | Welcome remarks 
5:20 PM | PreDxion Bio presentation (Took part in both JLABS & Y-Combinator Programs)
5:30 PM | Bio and healthcare at YC presentation
5:45 PM | JLABS & Health Tech @ JLABS presentation
6:00 PM | Q&A
6:15 PM | Networking reception
7:00 PM | Program Close
 


Venue:
JLABS @ SSF
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It


Fees: 
FREE | General Public 


Speakers' Biographies:  

Diego Rey | Visiting Partner, Y Combinator 
Diego Rey is a Visiting Partner at Y Combinator, a startup accelerator that has funded over 1,588 startups since 2005 with a combined market capitalization of over $80B. Prior to that Diego was a co-founder and the CTO of the clinical diagnostics startup GeneWEAVE, which was acquired by Roche, the global leader in in vitro diagnostics. GeneWEAVE is focused in advancing clinical microbiology with diagnostic solutions that will enable hospitals and physicians around the world to prevent and treat drug-resistant infections. Diego is originally from Patagonia, Argentina, he received BS in Electrical Engineering from UC Santa Barbara, and a PhD in Biomedical Engineering from Cornell University. 
Connect with Diego: Connect on LinkedIn 



Kate Merton | Head, JLABS @ NYC & Boston, Johnson & Johnson Innovation 
Kate Merton is Head of Johnson & Johnson Innovation, JLABS @ NYC. Kate has over 15 years of experience working across the Healthcare industry starting in R&D before moving onto roles in in Marketing, Business Development, External Alliances, Medical Affairs, Health Outcomes and most recently Disruptive Innovation. During her career Kate has been part of teams that have discovered new drugs, worked to develop and gain approval for blockbuster diabetes products and is passionate about being part of the future of healthcare where science intersects with the rapid advancements in health care technology. Kate received her undergraduate degree in Pharmacology & Toxicology from King’s College London, holds a PhD in Pharmacology & Toxicology from University of California, Irvine Medical School and received her MBA from the Fuqua School of Business at Duke University. 
Connect with Kate: Connect on LinkedIn 



Walker McHugh | Co-founder, PreDxion Bio 
Walker is a Co-founder and CEO of PreDxion Bio. PreDxion Bio has been granted Breakthrough Device Designation from the FDA, is backed by Y Combinator, and has received grant funding from the National Institutes of Health. PreDxion Bio is focused on fundamentally changing critical care medicine by leveraging the unique real-time insights into inflammatory biology provided by their bedside biomarker detection platform to develop best-in-class predictive algorithms and therapeutic decision making support. Walker is a graduate of the University of Michigan, completing undergraduate studies in immunology and further graduate training in the Medical Product Development Program at the University of Michigan College of Engineering. Walker has over ten years of basic science, clinical, and translational research experience, including eight publications, multiple national/international conference presentations, and multiple patent applications. Walker’s academic, research, and entrepreneurial activities are driven by his passion to better understand how inflammatory dysfunction drive critical illness for patients in the intensive care unit and emergency department, and disrupt how we care for these patients through precision medicine. Walker is a past Fellow in the Zell Global Entrepreneurship Program at the University of Michigan Business School and was named the 2017 University of Michigan Graduate Student Entrepreneur of the Year. 
Connect with Walker: Connect on LinkedIn 




JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content